Intuitive Surgical (ISRG) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $139.37B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | David J. Rosa |
| IPO Date | 2000-06-16 | CAGR | — |
| Employees | 17,021 | Website | www.intuitive.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 17.52% | Total Yield | 17.52% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $129.23B | P/E | 41.01 | Forward P/E | 32.68 | PEG | 1.74 |
| P/S | 1.85 | P/B | 1.13 | P/CF | 5.81 | P/FCF | 6.9 |
| Sales | $11.03B | Sales 1Y | 20.66% | Sales 3Y | 65.57% | Sales 5Y | 113.72% |
| EPS | $9.62 | EPS 1Y | 22.59% | EPS 3Y | 120.3% | EPS 5Y | 96.64% |
| Sales QoQ | 4.39% | EPS QoQ | 3.07% | Sales QoQ Avg | 4.53% | EPS QoQ Avg | 6.83% |
| Gross Margin | 66.29% | Operating Margin | 30.45% | Profit Margin | 28.15% | ROCE | 17.71% |
| ROA | 15% | ROE | 17% | Altman Z Score | 34.23 | Piotroski Score | 8 |
| Current Ratio | 6.03 | Quick Ratio | 5.01 | Cash Ratio | 1.07 | Op. CF Ratio | 1.38 |
| Debt/Equity | — | Debt/Assets | — | Lt Debt/Equity | — | Lt Debt/Cap. | — |
| Intrst Cov. | — | Inventory Turnover | 1.83 | Asset Turnover | 0.53 | Receivables Turnover | 6.18 |
| Enterprise Value | $129.23B | P/E Ratio | 41.01 |
| Forward P/E | 32.68 | PEG Ratio | 1.74 |
| P/S Ratio | 1.85 | P/B Ratio | 1.13 |
| P/CF Ratio | 5.81 | P/FCF Ratio | 6.9 |
| EPS | $9.62 | EPS Growth 1Y | 22.59% |
| EPS Growth 3Y | 120.3% | EPS Growth 5Y | 96.64% |
| Revenue Growth 1Y | 20.66% | Gross Margin | 0.66% |
| Operating Margin | 0.3% | Profit Margin | 0.28% |
| ROE | 0.17% | ROA | 0.15% |
| ROCE | 0.18% | Current Ratio | 6.03 |
| Quick Ratio | 5.01 | Cash Ratio | 1.07 |
| Debt/Equity | — | Interest Coverage | — |
| Altman Z Score | 34.23 | Piotroski Score | 8 |
Intuitive Surgical (ISRG) valuation & financials
Intuitive Surgical (ISRG) has a market capitalization of $139.37B and trades at a price-to-earnings ratio of 41.0. It operates in the Healthcare sector (Medical - Devices).
Intuitive Surgical's revenue grew +20.7% over the last year.
Intuitive Surgical's next earnings report is scheduled for October 20, 2026 after market close; analysts estimate EPS of $2.61. Check the earnings calendar to see all companies reporting this week.
Intuitive Surgical (ISRG) — frequently asked questions
When does Intuitive Surgical (ISRG) report earnings next?
Intuitive Surgical is expected to report earnings on October 20, 2026 after market close. Analysts estimate EPS of $2.61.
What is Intuitive Surgical's market cap?
Intuitive Surgical (ISRG) has a market capitalization of $139.37B.
What is ISRG's P/E ratio?
Intuitive Surgical trades at a price-to-earnings ratio of 41.0, with trailing twelve-month EPS of $9.62.
How fast is Intuitive Surgical growing?
Intuitive Surgical's revenue grew +20.7% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)